Inter Pharma
Inter Pharma Co., Ltd., commonly referred to as Inter Pharma, is a leading player in the pharmaceutical preparation manufacturing industry, headquartered in Thailand. Established in 1995, the company has made significant strides in developing high-quality pharmaceutical products, focusing on both prescription and over-the-counter medications.
With a strong presence in Southeast Asia, Inter Pharma is renowned for its innovative formulations and commitment to quality. The company’s core offerings include a diverse range of therapeutic products that cater to various medical needs, setting them apart through rigorous research and development processes.
Recognised for its excellence, Inter Pharma has achieved notable milestones, including certifications from international regulatory bodies, which underscore its dedication to safety and efficacy. As a trusted name in the pharmaceutical sector, Inter Pharma continues to enhance healthcare outcomes across the region.
-20 vs industry average
Inter Pharma’s score of 18 is lower than 26% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Inter Pharma?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Emissions trajectory 2020 – 2025
Reported emissions
Scope 3 accounts for ••• of total emissions.
Inter Pharma's reported carbon emissions
Inter Pharma, a pharmaceutical preparation manufacturer headquartered in Thailand, reported total carbon emissions of approximately 3.3 million kg CO2e for the year 2022. This figure encompasses Scope 1, Scope 2, and Scope 3 emissions, with Scope 2 contributing the largest portion at about 2.6 million kg CO2e. Scope 1 emissions amounted to approximately 567,880 kg CO2e, and Scope 3 emissions were around 53,120 kg CO2e. While Inter Pharma has disclosed data for all three scopes, certain Scope 3 categories, specifically purchased goods and services, were identified as missing data points for their 2022 reporting. Inter Pharma has not publicly disclosed specific reduction targets or participation in initiatives such as the Science Based Targets initiative (SBTi) at this time. The company's emissions data is not cascaded from a parent organisation, and their reporting is sourced from Inter Pharma Public Company Limited.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Inter Pharma’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Inter Pharma yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisations
Inter Pharma
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project